- 4.9Impact Factor
- 9.0CiteScore
- 21 daysTime to First Decision
Special Issues
Fishes publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Human Virome and Emerging Viruses: Characterization, Interactions, and Molecular Insights
Deadline: 31 May 2026
Molecular and Computational Innovations in Forensic Genetics: From Degraded DNA to Predictive Models
Deadline: 31 May 2026
Molecular Research of Gastrointestinal Disease, 3rd Edition
Deadline: 31 May 2026
Emerging Biomarkers in Cardiovascular Risk Assessment and Myocardial Injury
Deadline: 31 May 2026
Genetics and Molecular Mechanisms of Cancer Immunotherapy Response
Deadline: 31 May 2026
Drug Treatment for Bacterial Infections: 2nd Edition
Deadline: 31 May 2026
Signaling and Stress Adaptation in Plants: 2nd Edition
Deadline: 31 May 2026
Innovative Molecular Target and Therapeutic Approaches in Fatty Liver Disease
Deadline: 30 May 2026
Antimicrobial Materials: Novel Studies and Related Applications
Deadline: 30 May 2026
Nanostructured Strategies for Bioactive Compounds
Deadline: 30 May 2026
Molecular Mechanisms in Heart Rate Regulation and Cardiac Arrhythmias
Deadline: 30 May 2026
Design, Synthesis, and Biological Evaluation of Novel Bioactive Compounds
Deadline: 30 May 2026
of 863

